In contrast, neither early‐stage (Davidson et al. 2020) nor late‐stage (our data) MM primary tumors contain SAA3‐positive CAFs, suggesting that metastasis‐specific SAA3 expression might depend on the tumor entity. This evidence concerns the gene SAA3P and Miyoshi myopathy.